Home > Inhibitors & Agonists
Cat. No. Product name CAS No.
DCC3593 Nctu-alan-2026

Novel blocker of the interaction between FGF1 and FGFRD2 to inhibit cell proliferation, showing potent antiproliferent with less cytotoxicity.

DCC3594 ncx-2057

Novel NO-donor, suppressing inflammatory and nociceptive responses

475561-36-5
DCC3595 Ncx-6560

Novel HMG-CoA reductase inhibitor and nitric oxide donor

803728-45-2
DCC3596 N-cyano-sch-12679 Bromide

Cyanogen Bromide adduct of (R)-SCH-12679, a D1 antagonist

DCC3597 Levomepromazine Maleate

Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects

7104-38-3
DCC3598 Nd1-yl2

Novel degrader of steroid receptor co-activator 1 (SRC-1)

DCC3599 Nd-2110

Novel potent and highly specific IRAK4 inhibitor

1388894-17-4
DCC3600 Nd-322 Hydrochloride

Selective water-soluble gelatinase inhibitor

1333379-23-9
DCC3601 Nd-364

Potent and selective inhibitor for gelatinases, matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MPP9)

869577-61-7
DCC3602 nd7001

Inhibitor of Phosphodiesterase (PDE)-2

855170-53-5
DCC3603 N-demethyldiltiazem

Precursor for radiolabeled diltiazem

92700-53-3
DCC3604 N-desmethyl Loperamide

Major metabolite of loperamide, also used as the precusor for radiolabelled loperamide

66164-07-6
DCC3605 Ndi-10

Novel G4-DNA ligand, promoting transcription in Gram-positive bacteria and repressing transcription in Gram-negatives

DCC3606 Ndm-1 Inhibitor-2

Novel Inhibitor of New Delhi Metallo-β-lactamase-1 (NDM-1)

665013-76-3
DCC3607 nec-1i

Negative control compound for Necrostatin-1 related assays

64419-92-7
DCC3608 necrostatin-21

Novel necroptosis inhibitor

169136-33-8
DCC3609 necrox-18

Novel inhibitor of caspase-independent cell death with necrotic morphol, distinctly different from apoptosis, autophagy, and necroptosis, displaying strong mitochondrial reactive oxygen species and ONOO- scavenging activity

1174671-89-6
DCC3610 Nefopam

Non-narcotic analgesic for the relief of acute and chronic pain

13669-70-0
DCC3611 Neil1-in-p2

Novel Inhibitor of DNA Glycosylases, inhibiting NEIL1 activity

DCC3612 Nek2/7-in-51

Novel ATP-competitive inhibitor of Nek2 and Nek7

DCC3613 Neobractatin

Natural inhibitor of tumor metastasis by upregulating the RNA-binding-protein MBNL2, inducing cell cycle arrest through multiple signaling pathways including RNA binding protein CELF6

DCC3614 neocryptolepine

Inhibitor of the formation of

114414-78-7
DCC3615 Neothalfine

Potent natural anti-tumor agent against metastatic colorectal cancer, resulting in cell cycle arrest at the G2/M phase and inducing apoptosis through the dysfunction of mitochondria to trigger intrinsic apoptotic pathway by untargeted metabolomic method,

DCC3616 Nepetin [520-11-6]

Natural inducer of autophagy and apoptosis, inhibiting glutamate overexcitation and upregulation of the Wnt/β-catenin signaling pathway

520-11-6
DCC3617 Neq0502

Novel AR inhibitor, being selective for the testosterone stimulated AR-dependent prostate cancer cell

DCC3618 neq135

The first potent NAD-driven small molecular inhibitor of TcGAPDH (Trypanosoma cruzi glyceraldehyde 3-phosphate dehydrogenase)

224175-74-0
DCC3619 nequimed176

Novel non-peptidic, non-covalent cruzain inhibitor

1030685-11-0
DCC3620 Nesiritide Acetate

Human B-type natriuretic peptide, facilitating cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation

114471-18-0
DCC3621 Nestifylline

Anti-inflammatory, antibronchospastic agent

116763-36-1
DCC3622 Netarsudil Mesylate

Novel dual Rho Kinase and norepinephrine transporter (ROCK/NET) inhibitor

1422144-42-0
DCC3623 Net-c343

Novel fluorescent RXR antagonist

DCC3624 N-ethylglycine

Lidocaine metabolite, showing antinociceptive effects, inhibiting GlyT1-mediated glycine uptake

627-01-0
DCC3625 N-ethylmaleimide

Modulator of the T1007 site, resulting in rapid activation of this transporter and potentiating KCC2 activity

128-53-0
DCC3626 Neu321

Ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth

1426937-35-0
DCC3627 Neu-4854

Novel potent Trypanosoma brucei Inhibitor

DCC3628 Neu617

Novel inhibitor of the growth of protozoan parasites, against T. brucei bloodstream proliferation

1432450-82-2
DCC3629 Neu-730

Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation

1622300-88-2
DCC3630 Neurodazole

Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons

DCC3631 Neuroprotectant-7

Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB)

1610504-84-1
DCC3632 Neurotensin(8-13)

The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain

60482-95-3
DCC3633 Nexturastat A-crbn-12d

Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells

DCC3634 Nfat-133

Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities

DCC3635 Nf-kappab Inhibitor-2

First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation

DCC3636 N-formyl-met-phe

Neutrophil Dysfunction Test Peptide

22008-60-2
DCC3637 Nfu1827

Novel inhibitor of human cytomegalovirus (HCMV) infection

DCC3638 Ngd 98-2

New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist

355836-54-3
DCC3639 Ngd-8243

Novel TRPV1 Antagonist

573678-04-3
DCC3640 Ngd9002

New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist

666256-06-0
DCC3641 Ngp1-01

Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th

33226-57-2
DCC3642 Nh2-bodipy

Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells

DCC3643 Nh2-nplh2

Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo

1629640-37-4
DCC3644 Nh2-uamc1110

UAMC1110 Conjugate Linker

DCC3645 Nhi-1j

Selective Inhibitor of Human Lactate Dehydrogenase Isoform A (LDH-A)

1269802-68-7
DCC3646 Nicodicosapent

Novel inhibitor of the sterol regulatory element binding protein (SREBP)

1269181-69-2
DCC3647 Nicofibrate

Antilipidemic agent

31980-29-7
DCC3648 Nifrofam

Novel fluorescent probe for imaging α4β2* nAChRs

DCC3649 Nik-21273

Potent and selective NOP receptor antagonist

DCC3650 Nim811

Cyclophilin inhibitor, showing reduction in interleukin-2 expression and reduction in CNS inflammatory infiltrates, inhibiting HCoV-229E replication

143205-42-9
DCC3651 Ningetinib Tosylate

Novel potent tyrosine kinase inhibitor (TKI), targeting c-Met, VEGFR2 and Axl

1394820-77-9
DCC3652 Niraparib R-enantiomer

Novel potent PARP1 inhibitor

1038915-58-0
DCC3653 Nir-bg2

Novel self-immobilizing near-infrared (NIR) fluorogenic probe that can be activated by senescence-associated ß-galactosidase (SA-ß-Gal), the most widely used senescence marker

DCC3654 Nir-hs

Novel highly selective and sensitive near-infrared fluorescent probe for imaging of hydrogen sulphide in living cells and mice

DCC3655 Nir-ii Fluorophore-h1

Novel precursor of bright-emission NIR-II fluorophores for in vivo tumor imaging and image-guided surgery

DCC3656 Nirluc2

NIR emitting firefly luciferin analogue, displaying dose-independent improved NIR emission even at low concentrations where the native d-luciferin substrate does not emit

DCC3657 Nir-o2

Novel NIR NIR O2˙– probe, displays superior sensitivity to NIR O2˙– and having the capability to monitor trace amounts of intracellular NIR O2˙– in AKI in vivo

DCC3658 Nitd008

Antiviral agent against KFDV, AHFV, OHFV, as well as tick-borne encephalitis virus (TBEV) and mosquito-borne flaviviruses

1044589-82-3
DCC3659 nitro-r-flurbiprofen

Selective modulator of amyloid-beta peptide degradation, regulating Abeta levels

1374330-95-6
DCC3660 Nivocasan

Novel pan-caspase inhibitor, potently reducing not only inflammasome-mediated interleukin-1β (IL-1β) secretion but also osteoclast differentiation in BMMs

908253-63-4
DCC3661 Nizofenone Fumarate

Neuroprotective, protecting neurons from death following cerebral anoxia (interruption of oxygen supply to the brain).

54533-86-7
DCC3662 Nktr-102

Topoisomerase I inhibitor prodrug, slowly hydrolyzing and releasing irinotecan, increasing drug penetration into tumors and decreasing drug clearance

848779-32-8
DCC3663 Nld-22

Novel Enterovirus 71 Inhibitor, binding to the hydrophobic pocket in VP1 to block viral infection, exhibiting excellent antiviral activity (with an EC50 of 5.056 nM and a 100% protection rate for mice at a dose of 20 mg/kg) and low toxicity

DCC3664 Nlrp3 Inhibitor 4b

Novel NLRP3 inhibitor, reducing caspase-1 activation, oligomerization of ASC, and therefore, IL-1β processing, showing a significant anti-inflammatory effect and reduced mechanical hyperalgesia at 3 and 10 mg/kg (i.p.) in an in vivo mouse of gout

DCC3665 Nmac24

Novel Nm23-H1 activator, exerting cytotoxic effects on metastatic breast cancer cells by inducing mitochondrial dysfunction only under glucose starvation

DCC3666 nmda167-3

Novel inhibitor of the Gli1 transcription, inducing apoptosis in cancer cells but not in non-cancerous cells

1239447-58-5
DCC3667 Nmda298-1

Novel inhibitor of glioma-associated oncogene homologue 1 (Gli1) mediated transcription

DCC3668 Nmdi14

Novel Inhibitor of Nonsense-Mediated RNA Decay, Suppressing Nonsense p53 Mutations

307519-88-6
DCC3669 N-me-aminopyrimidinone 9

Potent and state-dependent Nav1.7 antagonist

1356834-62-2
DCC3670 Nmi801

Novel Mdm2 inhibitor, acting as a negative regulator of p53, reducing viability in cell culture and suppressing tumor growth

DCC3671 nmk-td-100

Novel Microtubule Modulator, Blocking Mitosis and Inducing Apoptosis in HeLa Cells by Binding to Tubulin

1252802-38-2
DCC3672 nms859

Covalent and allosteric inhibitor of the ATPase VCP/p97, inducing cancer cell death

1449236-96-7
DCC3673 Nms-p715 Analog

Novel selective and orally bioavailable MPS1 inhibitor

1202055-34-2
DCC3674 Nms-p953

Novel JAK2 inhibitor, displaying significant tumor growth inhibition in SET-​2 xenograft tumor model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile

1403679-33-3
DCC3675 Nn9056

Novel Potent and Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor (CCK-1R) Agonist

DCC3676 N-n-butyl Haloperidol Iodide

Novel inhibitor of autophagy, protecting cardiomyocytes against hypoxia/reoxygenation injury

DCC3677 Nnc-38-1049

Novel selective histamine H3 antagonist

757183-18-9
DCC3678 Nn-dnj

Iminosugar, binding to the active site of lysosomal beta-glucosidase and stabilizing the proper folding for the catalytic form, acting as a chemical chaperone that facilitate transport and maturation of acid beta-Glu

81117-35-3
DCC3679 Nnmt Inhibitor Ns1

Novel potent alkynyl bisubstrate inhibitor of nicotinamide N-methyltransferase (NNMT)

DCC3680 nnrti F2

Novel non-nucleoside reverse transcriptase inhibitor (NNRTI)

1152034-94-0
DCC3681 Nocardicin A

Moderate antibiotic agent against a broad spectrum of gram-negative bacteria

39391-39-4
DCC3682 Nocardicin G

The universal precursor of the nocardicins

65309-11-7
DCC3683 Nocathiacin I

Natural Inhibitor of an Oncogenic RNA, targeting RNA folds in the nuclease processing site in the oncogenic, noncoding microRNA-18a, selectively inhibiting nuclease processing in vitro and in prostate cancer cells and triggering apoptosis

214044-52-7
DCC3684 nocazine C

Nocazine family member

1421460-89-0
DCC3685 nocazine E

Marine natural nocazine family member; Standard used in nocazine biosynthetic parthway studies

1421460-90-3
DCC3686 Nociceptin

Neuropeptide, acting as a endogenous ligand for the nociceptin receptor (NOP, ORL-1)

170713-75-4
DCC3687 N-oleoylethanolamine

PPARalpha agonist and EC 3.5.1.23 (ceramidase) inhibitor

111-58-0
DCC3688 Nomegestrol

Steroidal progestin

58691-88-6
DCC3689 Nomegestrol Acetate

Neutral, nonandrogenic, progesterone-like profile progestin

58652-20-3
DCC3690 Nonoxynol-9

Novel human epidermal growth factor receptor-2 (HER2) inhibitor; Spermatocide

26571-11-9
DCC3691 Nord-1

Novel red-light-controllable nitric oxide (NO) releaser

DCC3692 Nor-fauc-365

FAUC-365 analog

DCC3693 Norgestomet

Steroidal progestin used in veterinary medicine to control estrus and ovulation in cattle

25092-41-5
DCC3694 Noricumazole A

Secondary metabolite from the myxobacterium Sorangium cellulosum, acting as a potent HCV inhibitor, Ebola virus (EBOV) entry inhibitor, and a potassium channel inhibitor

DCC3695 No-rosa5

Controllable nitric oxide (NO) donor, releasing NO triggered by photoinduced electron transfer (PeT)

DCC3696 Noscapine

Natueal sigma receptor agonist, attenuating cytokine release associated with SARS-CoV-2, also being used as anti-malarial, anti-stroke and cough-suppressant

128-62-1
DCC3697 Notum-in-23dd

Novel potent inhibitor of notum carboxylesterase activity

DCC3698 Notum-in-24

Novel potent notum inhibitor (OPTS IC50 3.6nM; TCF-LEF EC50 220nM), showing good plasma exposure and reasonable CNS penetration

DCC3699 Nov-lrrk2-11

Novel potent LRRK2 inhibitor

DCC3700 Novolactone

Natural inhibitor of the allosteric regulation of Hsp70

1804950-46-6
DCC3701 Np-005497

Natural inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thaliana

DCC3702 Npa101.3

Second-Generation RET/VEGFR2 Inhibitor

1839155-15-5
DCC3703 Np-c86

Novel stabilizer of long noncoding RNA (lncRNA) GAS5, binding to GAS5 with high affinity, and increasing GAS5 levels and glucose uptake in diabetic patient adipocytes

DCC3704 Npd-008

Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)

2229043-42-7
DCC3705 Npd-039

Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1)

2229043-40-5
DCC3706 Npd-048

Novel inhibitor of Trypanosoma brucei PDEB1 (TbrPDEB1)

DCC3707 Npd11033

Novel selective SIRT2 inhibitor, creating a hydrophobic cavity behind the substrate-binding pocket after a conformational change of the Zn-binding small domain of SIRT2

DCC3708 Npd12671

Novel activator of 15-ADON production, significantly increasing the transcription of Tri6, a transcription factor gene necessary for trichothecene biosynthesis, in both trichothecene-inducing and noninducing culture conditions

865282-76-4
DCC3709 Npd2639

Novel biomediator, inducing reveromycin production in Streptomyces sp. SN-593

859130-76-0
DCC3710 Npd6689

Novel tubulin inhibitor

859671-40-2
DCC3711 Npd7155

Novel competitive MTH1 inhibitor

924764-38-5
DCC3712 Npd8617

Novel tubulin inhibitor

313481-28-6
DCC3713 Npd9055

Novel heterotrimeric G-protein Gi modulator, inhibiting GDP/GTP exchange on a Gαi subunit induced by a G-protein-coupled receptor agonist, but not on another G-protein from the Gαs family, regulating Gβγ-dependent cellular processes, most likely by causin

327102-63-6
DCC3714 Nplc0393

Novel inhibitor of TGF-β1 signaling pathway, inhibiting the upregulation of MAT2A mechanistically, dose-dependently activating PP2Cα and efficiently alleviating liver fibrosis

862286-45-1
DCC3715 Npr-c Activator 1

Novel potent activator of the natriuretic peptide receptor C (NPR-C) with EC 50 ~1 μM

DCC3716 Nps-89636

Calcilytic negative allosteric modulator of calcium-sensing receptor (CaR)

1588949-48-7
DCC3717 Nqo1 Substrate 1

Novel substrate for NAD(P)H: quinone oxidoreductase 1 (NQO1), acting as an effective intracellular ROS generator for the treatment of drug-resistant non-small-cell lung cancer

2304503-05-5
DCC3718 Nr2b-in-1

Novel NMDA/NR2B Antagonist

913574-42-2
DCC3719 Nrf2/ho-1 Activator Ll202

Novel activator of the Nrf2/HO-1 pathway, upregulating heme oxygenase-1 (HO-1) via promoting nuclear translocation of nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) to regulate LPS‐induced oxidative stress in macrophages

DCC3720 Nrf2-activator Featured

Nrf2-Activator is a potent Nrf-2 activator.

1554271-18-9
DCC3721 Ns-0011

Novel inhibitor of CDK5 translocation, increasing CDK5 accumulation in the nucleus, suppressing both cancer cell proliferation and xenograft tumorigenesis.

1076234-33-7
DCC3722 Ns-2710

Potent, non-selective partial agonist at GABAA receptors with little efficacy at the alpha1 subtype and more at alpha2 and alpha3

184220-36-8
DCC3723 ns3/4a-in-12

Novel Inhibitor with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes

DCC3724 ns3-in-5

Novel allosteric inhibitor of HCV NS3 protein function

1434713-38-8
DCC3725 Ns4591

Novel molulator of SK-IK channels [small- and intermediate-conductance Ca2(+) -activated K(+) channels]

273930-52-2
DCC3726 Ns-6740

Novel potent α7 nAChR partial agonist

753499-14-8
DCC3727 Ns-6784 Hydrochloride

Novel α7 nAChR agonist at human and rat receptors

677723-97-6
DCC3728 Nsc10010

Novel potent growth inhibitor for gammaherpesvirus-associated B-lymphomas through activation of both the NF-κB and c-Myc-mediated signaling pathways

6286-09-5
DCC3729 Nsc1008

Novel Inhibitor of the Ras Converting Enzyme 1 (Rce1) Protease, Disrupting Ras Membrane Localization in Human Cells

5335-95-5
DCC3730 Nsc-100874

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

1135059-20-9
DCC3731 Nsc1011

Ras converting enzyme 1 (Rce1) inhibitor

5335-97-7
DCC3732 Nsc103054

Novel inhibitor of ABCG2 transporter function

19590-55-7
DCC3733 Nsc-104999

Ligand of the Grb7 SH2 domain, inhibiting the growth of MDA-MB-468 cancer cells

1118745-14-4
DCC3734 Nsc107392

Novel substrate of ABCG2

19494-89-4
DCC3735 Nsc109131

Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1)

21170-27-4
DCC3736 Nsc109779

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

DCC3737 Nsc114792

Novel selective inhibitor of JAK3

17392-79-9
DCC3738 Nsc-117199

Selective inhibitor of shp2 protein tyrosine phosphatase (PTP)

21303-44-6
DCC3739 Nsc-12404

Selective non-lipid agonist of LPA2/3

5411-64-3
DCC3740 Nsc-126188

Apoptosis inducer; Antitumor agent

31863-82-8
DCC3741 Nsc127133

Novel inhibitor of the second bromodomain (BD2) of the BET family protein BRD2

DCC3742 Nsc-13030

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

5442-51-3
DCC3743 Nsc-134754

HIF-pathway inhibitor

75041-32-6
DCC3744 Nsc13987

Novel inhibitor of Nef-calnexin interaction

81-94-7
DCC3745 Nsc-140873

Inhibitor of the RUNX1-CBFβ interaction

106410-13-3
DCC3746 Nsc16168

Specific inhibitor of ERCC1-XPF with no effect on both HhaI and XPG

6837-93-0
DCC3747 Nsc175176

Novel potent and selective serotonin reuptake inhibitor (SSRI)

DCC3748 nsc-176327

Selective G-quadruplex inducer of the human telomeric sequence; Stabilizer of the G-quadruplex formed by the MYC promoter sequence; Anti-neoplastic effects in wild-type p53, p53-mutant or p53-deficient human colon cancer cells.

85632-83-3
DCC3749 Nsc-176377

Non-nucleoside reverse transcriptase inhibitor

20841-26-3
DCC3750 Nsc-18725

Novel inhibitor of growth of intracellular Mycobacterium tuberculosis, inducing autophagy in differentiated THP-1 macrophages

715-99-1
DCC3751 nsc-20596

Capturer of kinase-insertion domain receptor (KDR) from a solution, while allowing the captured KDR to bind with the solution-phase vascular endothelial growth factor (VEGF)

6976-14-3
DCC3752 Nsc24048

Novel inhibitor of ABCG2 transporter function

5459-47-2
DCC3753 Nsc-24198

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

7152-78-5
DCC3754 Nsc24674

Novel 3C-like protease inhibitor of SARS-CoV-2

DCC3755 Nsc-2488 [5459-61-0]

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5459-61-0
DCC3756 nsc-252359

Specific Ligand for Stem Loop 3 Ribonucleic Acid of the Packaging Signal Ψ of Human Immunodeficiency Virus-1

500889-59-8
DCC3757 Nsc265473

Novel substrate of ABCG2

61786-74-1
DCC3758 Nsc-279287

Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells

59541-35-4
DCC3759 Nsc-2888

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5335-14-8
DCC3760 Nsc-299202

Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)

49635-47-4
DCC3761 Nsc30049

Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

DCC3762 Nsc-311068

Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1

73768-68-0
DCC3763 Nsc-33353

Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA

DCC3764 Nsc-339579

Novel potent Mycobacterium tuberculosis DHFR inhibitor

65795-53-1
DCC3765 Nsc339614 Potassium Salt

Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors

1135037-53-4
DCC3766 Nsc-347518

DT-diaphorase inhibitor

87626-58-2
DCC3767 Nsc-4231

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

5397-55-7
DCC3768 nsc48693 Dihydrochloride

Potent apoptosis inducer in pancreatic cancer cells

1356084-90-6
DCC3769 Nsc52101

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

DCC3770 Nsc-55158

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

5507-11-9
DCC3771 Nsc56452

Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer

DCC3772 Nsc-57148

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

4315-44-0
DCC3773 Nsc-57774

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

524-11-8
DCC3774 Nsc57971

Novel non-peptide disruptor of IKKß/NEMO complex

6632-11-7
DCC3775 Nsc-60339

Novel efflux pump inhibitor (EPI)

70-09-7
DCC3776 Nsc61610

Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator

500538-94-3
DCC3777 Nsc-627757

Novel DNA repair inhibitor

DCC3778 Nsc636795

Novel inhibitor of ABCG2 transporter function

66528-28-7
DCC3779 Nsc-657186

Novel selective non-zinc-binding MMP-2 inhibitor

1772-39-0
DCC3780 Nsc65847

Novel dual inhibitor of viral and Streptococcus pneumoniae neuraminidase

6949-15-1
DCC3781 Nsc66098

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

3259-43-6
DCC3782 Nsc663627

IκBα phosphorylation inhibitor

51837-75-3
DCC3783 Nsc-670224

Toxitant of Saccharomyces_cerevisiae>Saccharomyces cerevisiae

1374648-47-1
DCC3784 Nsc-672121

Potent CDC25A>Cdc25A inhibitor; Vitamine K3 analogue

59147-84-1
DCC3785 Nsc-674205

Potent and selective nociceptin opioid receptor (NOP) agonist

13130-47-7
DCC3786 Nsc676914a

Novel NF-κB inhibitor

DCC3787 nsc-681152

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27(Kip1) ubiquitination in vitro

241128-06-3
DCC3788 Nsc-689857

Novel inhibitor of the Skp2-Cks1 protein-protein interaction and p27Kip1 ubiquitination in vitro

241127-79-7
DCC3789 Nsc704342

Novel Inhibitor of HCV NS3/4A Proteinase

DCC3790 Nsc705841

Novel selective serotonin reuptake inhibitor (SSRI), exhibiting higher binding affinities in comparison with the paroxetine

DCC3791 Nsc724526

Novel Inhibitor of HCV NS3/4A Proteinase

DCC3792 Nsc724527

Novel Inhibitor of HCV NS3/4A Proteinase

<Prev1...170171172173174...191Next>